nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—NR0B1—Vincristine—sarcoma	0.501	1	CbGbCtD
Vorinostat—HDAC1—manus—sarcoma	0.00662	0.0503	CbGeAlD
Vorinostat—HDAC1—manual digit—sarcoma	0.00647	0.0492	CbGeAlD
Vorinostat—Ureteric obstruction—Mitoxantrone—sarcoma	0.00606	0.0506	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Etoposide—sarcoma	0.00504	0.0421	CcSEcCtD
Vorinostat—HDAC2—Teniposide—Etoposide—sarcoma	0.00283	1	CbGdCrCtD
Vorinostat—Gastrointestinal toxicity—Epirubicin—sarcoma	0.00283	0.0236	CcSEcCtD
Vorinostat—Ureteric obstruction—Epirubicin—sarcoma	0.00283	0.0236	CcSEcCtD
Vorinostat—Ureteric obstruction—Doxorubicin—sarcoma	0.00262	0.0218	CcSEcCtD
Vorinostat—Gastrointestinal toxicity—Doxorubicin—sarcoma	0.00262	0.0218	CcSEcCtD
Vorinostat—HDAC11—hematopoietic system—sarcoma	0.00254	0.0193	CbGeAlD
Vorinostat—HDAC3—myometrium—sarcoma	0.00252	0.0191	CbGeAlD
Vorinostat—NCOR1—hematopoietic system—sarcoma	0.00246	0.0187	CbGeAlD
Vorinostat—Myelosuppression—Thiotepa—sarcoma	0.00246	0.0205	CcSEcCtD
Vorinostat—Myelosuppression—Dactinomycin—sarcoma	0.00244	0.0204	CcSEcCtD
Vorinostat—HDAC3—embryo—sarcoma	0.00242	0.0184	CbGeAlD
Vorinostat—NCOR1—connective tissue—sarcoma	0.00237	0.018	CbGeAlD
Vorinostat—HDAC1—myometrium—sarcoma	0.0023	0.0175	CbGeAlD
Vorinostat—HDAC3—seminal vesicle—sarcoma	0.00227	0.0173	CbGeAlD
Vorinostat—HDAC1—embryo—sarcoma	0.00222	0.0168	CbGeAlD
Vorinostat—HDAC8—uterus—sarcoma	0.0022	0.0167	CbGeAlD
Vorinostat—Myelosuppression—Vincristine—sarcoma	0.00218	0.0182	CcSEcCtD
Vorinostat—HDAC3—hematopoietic system—sarcoma	0.00216	0.0164	CbGeAlD
Vorinostat—NCOR1—skin of body—sarcoma	0.00214	0.0163	CbGeAlD
Vorinostat—HDAC4—uterus—sarcoma	0.00214	0.0163	CbGeAlD
Vorinostat—Myelosuppression—Mitoxantrone—sarcoma	0.00212	0.0177	CcSEcCtD
Vorinostat—HDAC1—seminal vesicle—sarcoma	0.00208	0.0158	CbGeAlD
Vorinostat—HDAC3—connective tissue—sarcoma	0.00208	0.0158	CbGeAlD
Vorinostat—HDAC1—hematopoietic system—sarcoma	0.00198	0.015	CbGeAlD
Vorinostat—HDAC9—hematopoietic system—sarcoma	0.00195	0.0148	CbGeAlD
Vorinostat—HDAC8—tendon—sarcoma	0.00193	0.0147	CbGeAlD
Vorinostat—HDAC11—uterus—sarcoma	0.00192	0.0146	CbGeAlD
Vorinostat—HDAC1—connective tissue—sarcoma	0.0019	0.0145	CbGeAlD
Vorinostat—HDAC3—skin of body—sarcoma	0.00188	0.0143	CbGeAlD
Vorinostat—HDAC4—tendon—sarcoma	0.00187	0.0142	CbGeAlD
Vorinostat—HDAC8—bone marrow—sarcoma	0.00187	0.0142	CbGeAlD
Vorinostat—NCOR1—uterus—sarcoma	0.00186	0.0142	CbGeAlD
Vorinostat—HDAC4—bone marrow—sarcoma	0.00181	0.0138	CbGeAlD
Vorinostat—HDAC6—testis—sarcoma	0.0018	0.0137	CbGeAlD
Vorinostat—Embolism—Thiotepa—sarcoma	0.0018	0.015	CcSEcCtD
Vorinostat—HDAC11—lymphoid tissue—sarcoma	0.00179	0.0136	CbGeAlD
Vorinostat—Myelosuppression—Etoposide—sarcoma	0.00177	0.0147	CcSEcCtD
Vorinostat—HDAC1—smooth muscle tissue—sarcoma	0.00174	0.0132	CbGeAlD
Vorinostat—NCOR1—lymphoid tissue—sarcoma	0.00173	0.0132	CbGeAlD
Vorinostat—HDAC1—skin of body—sarcoma	0.00172	0.0131	CbGeAlD
Vorinostat—HDAC6—liver—sarcoma	0.0017	0.0129	CbGeAlD
Vorinostat—HDAC3—cardiac atrium—sarcoma	0.00164	0.0125	CbGeAlD
Vorinostat—HDAC2—mammary gland—sarcoma	0.00163	0.0124	CbGeAlD
Vorinostat—HDAC3—uterus—sarcoma	0.00163	0.0124	CbGeAlD
Vorinostat—Serum creatinine increased—Mitoxantrone—sarcoma	0.00162	0.0135	CcSEcCtD
Vorinostat—HDAC8—testis—sarcoma	0.0016	0.0121	CbGeAlD
Vorinostat—NCOR1—bone marrow—sarcoma	0.00158	0.012	CbGeAlD
Vorinostat—HDAC4—testis—sarcoma	0.00155	0.0118	CbGeAlD
Vorinostat—HDAC3—lymphoid tissue—sarcoma	0.00152	0.0116	CbGeAlD
Vorinostat—HDAC8—liver—sarcoma	0.00151	0.0115	CbGeAlD
Vorinostat—HDAC1—cardiac atrium—sarcoma	0.0015	0.0114	CbGeAlD
Vorinostat—HDAC1—uterus—sarcoma	0.00149	0.0114	CbGeAlD
Vorinostat—HDAC9—uterus—sarcoma	0.00147	0.0112	CbGeAlD
Vorinostat—HDAC4—liver—sarcoma	0.00147	0.0111	CbGeAlD
Vorinostat—Thromboembolism—Epirubicin—sarcoma	0.00146	0.0122	CcSEcCtD
Vorinostat—HDAC3—tendon—sarcoma	0.00143	0.0109	CbGeAlD
Vorinostat—HDAC1—lymphoid tissue—sarcoma	0.00139	0.0106	CbGeAlD
Vorinostat—HDAC11—testis—sarcoma	0.00139	0.0106	CbGeAlD
Vorinostat—HDAC3—bone marrow—sarcoma	0.00138	0.0105	CbGeAlD
Vorinostat—HDAC9—lymphoid tissue—sarcoma	0.00137	0.0104	CbGeAlD
Vorinostat—NCOR1—testis—sarcoma	0.00135	0.0103	CbGeAlD
Vorinostat—Thromboembolism—Doxorubicin—sarcoma	0.00135	0.0113	CcSEcCtD
Vorinostat—Neoplasm malignant—Thiotepa—sarcoma	0.00135	0.0113	CcSEcCtD
Vorinostat—HDAC1—tendon—sarcoma	0.00131	0.00995	CbGeAlD
Vorinostat—HDAC6—lymph node—sarcoma	0.0013	0.00992	CbGeAlD
Vorinostat—HDAC9—tendon—sarcoma	0.00129	0.00979	CbGeAlD
Vorinostat—NCOR1—liver—sarcoma	0.00128	0.00971	CbGeAlD
Vorinostat—HDAC1—bone marrow—sarcoma	0.00127	0.00964	CbGeAlD
Vorinostat—NR0B1—testis—sarcoma	0.00127	0.00964	CbGeAlD
Vorinostat—HDAC9—bone marrow—sarcoma	0.00125	0.00948	CbGeAlD
Vorinostat—HDAC3—testis—sarcoma	0.00118	0.009	CbGeAlD
Vorinostat—HDAC8—lymph node—sarcoma	0.00116	0.0088	CbGeAlD
Vorinostat—Proteinuria—Mitoxantrone—sarcoma	0.00113	0.00946	CcSEcCtD
Vorinostat—HDAC4—lymph node—sarcoma	0.00112	0.00855	CbGeAlD
Vorinostat—HDAC3—liver—sarcoma	0.00112	0.00851	CbGeAlD
Vorinostat—Protein urine present—Mitoxantrone—sarcoma	0.00112	0.00933	CcSEcCtD
Vorinostat—HDAC2—embryo—sarcoma	0.00111	0.00847	CbGeAlD
Vorinostat—HDAC1—testis—sarcoma	0.00108	0.00824	CbGeAlD
Vorinostat—HDAC9—testis—sarcoma	0.00107	0.00811	CbGeAlD
Vorinostat—HDAC1—liver—sarcoma	0.00102	0.00779	CbGeAlD
Vorinostat—HDAC11—lymph node—sarcoma	0.00101	0.00767	CbGeAlD
Vorinostat—Sepsis—Thiotepa—sarcoma	0.001	0.00835	CcSEcCtD
Vorinostat—HDAC2—hematopoietic system—sarcoma	0.000995	0.00756	CbGeAlD
Vorinostat—Sepsis—Dactinomycin—sarcoma	0.000993	0.00829	CcSEcCtD
Vorinostat—Myelosuppression—Epirubicin—sarcoma	0.00099	0.00826	CcSEcCtD
Vorinostat—NCOR1—lymph node—sarcoma	0.000979	0.00744	CbGeAlD
Vorinostat—HDAC2—connective tissue—sarcoma	0.000958	0.00728	CbGeAlD
Vorinostat—Embolism venous—Epirubicin—sarcoma	0.000919	0.00768	CcSEcCtD
Vorinostat—Myelosuppression—Doxorubicin—sarcoma	0.000916	0.00764	CcSEcCtD
Vorinostat—HDAC2—smooth muscle tissue—sarcoma	0.000876	0.00666	CbGeAlD
Vorinostat—HDAC2—skin of body—sarcoma	0.000865	0.00658	CbGeAlD
Vorinostat—Sepsis—Mitoxantrone—sarcoma	0.000864	0.00721	CcSEcCtD
Vorinostat—HDAC3—lymph node—sarcoma	0.000858	0.00652	CbGeAlD
Vorinostat—Embolism venous—Doxorubicin—sarcoma	0.000851	0.0071	CcSEcCtD
Vorinostat—Lethargy—Dactinomycin—sarcoma	0.000847	0.00707	CcSEcCtD
Vorinostat—HDAC1—lymph node—sarcoma	0.000786	0.00597	CbGeAlD
Vorinostat—Blood creatinine increased—Thiotepa—sarcoma	0.000784	0.00654	CcSEcCtD
Vorinostat—Dehydration—Thiotepa—sarcoma	0.000778	0.0065	CcSEcCtD
Vorinostat—HDAC9—lymph node—sarcoma	0.000773	0.00588	CbGeAlD
Vorinostat—Serum creatinine increased—Epirubicin—sarcoma	0.000754	0.0063	CcSEcCtD
Vorinostat—HDAC2—uterus—sarcoma	0.000751	0.00571	CbGeAlD
Vorinostat—Embolism—Epirubicin—sarcoma	0.000723	0.00604	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Mitoxantrone—sarcoma	0.000722	0.00603	CcSEcCtD
Vorinostat—Sepsis—Etoposide—sarcoma	0.000718	0.006	CcSEcCtD
Vorinostat—HDAC2—lymphoid tissue—sarcoma	0.0007	0.00532	CbGeAlD
Vorinostat—Serum creatinine increased—Doxorubicin—sarcoma	0.000698	0.00583	CcSEcCtD
Vorinostat—Dehydration—Vincristine—sarcoma	0.00069	0.00576	CcSEcCtD
Vorinostat—Pancytopenia—Thiotepa—sarcoma	0.000687	0.00573	CcSEcCtD
Vorinostat—Pancytopenia—Dactinomycin—sarcoma	0.000681	0.00569	CcSEcCtD
Vorinostat—Blood creatinine increased—Mitoxantrone—sarcoma	0.000677	0.00565	CcSEcCtD
Vorinostat—Dehydration—Mitoxantrone—sarcoma	0.000672	0.00561	CcSEcCtD
Vorinostat—Neutropenia—Dactinomycin—sarcoma	0.000671	0.0056	CcSEcCtD
Vorinostat—Embolism—Doxorubicin—sarcoma	0.000669	0.00558	CcSEcCtD
Vorinostat—HDAC2—tendon—sarcoma	0.000658	0.00501	CbGeAlD
Vorinostat—Hypokalaemia—Mitoxantrone—sarcoma	0.000657	0.00549	CcSEcCtD
Vorinostat—Hyperglycaemia—Thiotepa—sarcoma	0.000652	0.00545	CcSEcCtD
Vorinostat—HDAC2—bone marrow—sarcoma	0.000638	0.00485	CbGeAlD
Vorinostat—Pancytopenia—Vincristine—sarcoma	0.000609	0.00508	CcSEcCtD
Vorinostat—Neutropenia—Vincristine—sarcoma	0.000599	0.00501	CcSEcCtD
Vorinostat—Pancytopenia—Mitoxantrone—sarcoma	0.000593	0.00495	CcSEcCtD
Vorinostat—Abscess—Epirubicin—sarcoma	0.000586	0.0049	CcSEcCtD
Vorinostat—Neutropenia—Mitoxantrone—sarcoma	0.000584	0.00487	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00058	0.00484	CcSEcCtD
Vorinostat—Weight decreased—Vincristine—sarcoma	0.00058	0.00484	CcSEcCtD
Vorinostat—Weight decreased—Mitoxantrone—sarcoma	0.000565	0.00472	CcSEcCtD
Vorinostat—Acute coronary syndrome—Vincristine—sarcoma	0.000564	0.0047	CcSEcCtD
Vorinostat—Hyperglycaemia—Mitoxantrone—sarcoma	0.000563	0.0047	CcSEcCtD
Vorinostat—Myocardial infarction—Vincristine—sarcoma	0.00056	0.00468	CcSEcCtD
Vorinostat—Acute coronary syndrome—Mitoxantrone—sarcoma	0.000549	0.00458	CcSEcCtD
Vorinostat—Myocardial infarction—Mitoxantrone—sarcoma	0.000546	0.00456	CcSEcCtD
Vorinostat—HDAC2—testis—sarcoma	0.000545	0.00414	CbGeAlD
Vorinostat—Neoplasm malignant—Epirubicin—sarcoma	0.000543	0.00454	CcSEcCtD
Vorinostat—Abscess—Doxorubicin—sarcoma	0.000543	0.00453	CcSEcCtD
Vorinostat—Chills—Thiotepa—sarcoma	0.000519	0.00434	CcSEcCtD
Vorinostat—Chills—Dactinomycin—sarcoma	0.000515	0.0043	CcSEcCtD
Vorinostat—HDAC2—liver—sarcoma	0.000515	0.00392	CbGeAlD
Vorinostat—Alopecia—Thiotepa—sarcoma	0.000511	0.00427	CcSEcCtD
Vorinostat—Alopecia—Dactinomycin—sarcoma	0.000508	0.00424	CcSEcCtD
Vorinostat—Neoplasm malignant—Doxorubicin—sarcoma	0.000503	0.0042	CcSEcCtD
Vorinostat—Pancytopenia—Etoposide—sarcoma	0.000493	0.00412	CcSEcCtD
Vorinostat—Neutropenia—Etoposide—sarcoma	0.000486	0.00405	CcSEcCtD
Vorinostat—Anaemia—Thiotepa—sarcoma	0.000466	0.00389	CcSEcCtD
Vorinostat—Pulmonary embolism—Epirubicin—sarcoma	0.000464	0.00387	CcSEcCtD
Vorinostat—Anaemia—Dactinomycin—sarcoma	0.000462	0.00386	CcSEcCtD
Vorinostat—Acute coronary syndrome—Etoposide—sarcoma	0.000456	0.00381	CcSEcCtD
Vorinostat—Myocardial infarction—Etoposide—sarcoma	0.000454	0.00379	CcSEcCtD
Vorinostat—Alopecia—Vincristine—sarcoma	0.000453	0.00379	CcSEcCtD
Vorinostat—Leukopenia—Thiotepa—sarcoma	0.000451	0.00376	CcSEcCtD
Vorinostat—Chills—Mitoxantrone—sarcoma	0.000448	0.00374	CcSEcCtD
Vorinostat—Leukopenia—Dactinomycin—sarcoma	0.000448	0.00374	CcSEcCtD
Vorinostat—Alopecia—Mitoxantrone—sarcoma	0.000442	0.00369	CcSEcCtD
Vorinostat—Cough—Thiotepa—sarcoma	0.00044	0.00367	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—sarcoma	0.000429	0.00358	CcSEcCtD
Vorinostat—Dysgeusia—Mitoxantrone—sarcoma	0.000426	0.00356	CcSEcCtD
Vorinostat—Anaemia—Vincristine—sarcoma	0.000413	0.00345	CcSEcCtD
Vorinostat—Infection—Thiotepa—sarcoma	0.000408	0.00341	CcSEcCtD
Vorinostat—Infection—Dactinomycin—sarcoma	0.000405	0.00338	CcSEcCtD
Vorinostat—Sepsis—Epirubicin—sarcoma	0.000403	0.00336	CcSEcCtD
Vorinostat—Thrombocytopenia—Thiotepa—sarcoma	0.000403	0.00336	CcSEcCtD
Vorinostat—Anaemia—Mitoxantrone—sarcoma	0.000402	0.00336	CcSEcCtD
Vorinostat—Leukopenia—Vincristine—sarcoma	0.0004	0.00334	CcSEcCtD
Vorinostat—Thrombocytopenia—Dactinomycin—sarcoma	0.0004	0.00334	CcSEcCtD
Vorinostat—HDAC2—lymph node—sarcoma	0.000395	0.003	CbGeAlD
Vorinostat—Anorexia—Thiotepa—sarcoma	0.000392	0.00327	CcSEcCtD
Vorinostat—Leukopenia—Mitoxantrone—sarcoma	0.000389	0.00325	CcSEcCtD
Vorinostat—Anorexia—Dactinomycin—sarcoma	0.000389	0.00325	CcSEcCtD
Vorinostat—Cough—Mitoxantrone—sarcoma	0.00038	0.00317	CcSEcCtD
Vorinostat—Chills—Etoposide—sarcoma	0.000373	0.00311	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—sarcoma	0.000373	0.00311	CcSEcCtD
Vorinostat—Chest pain—Mitoxantrone—sarcoma	0.00037	0.00309	CcSEcCtD
Vorinostat—Alopecia—Etoposide—sarcoma	0.000367	0.00307	CcSEcCtD
Vorinostat—Infection—Vincristine—sarcoma	0.000362	0.00302	CcSEcCtD
Vorinostat—Decreased appetite—Thiotepa—sarcoma	0.000357	0.00298	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Epirubicin—sarcoma	0.000357	0.00298	CcSEcCtD
Vorinostat—Thrombocytopenia—Vincristine—sarcoma	0.000357	0.00298	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Thiotepa—sarcoma	0.000355	0.00296	CcSEcCtD
Vorinostat—Decreased appetite—Dactinomycin—sarcoma	0.000355	0.00296	CcSEcCtD
Vorinostat—Fatigue—Thiotepa—sarcoma	0.000354	0.00296	CcSEcCtD
Vorinostat—Dysgeusia—Etoposide—sarcoma	0.000354	0.00296	CcSEcCtD
Vorinostat—Infection—Mitoxantrone—sarcoma	0.000353	0.00295	CcSEcCtD
Vorinostat—Fatigue—Dactinomycin—sarcoma	0.000352	0.00294	CcSEcCtD
Vorinostat—Constipation—Thiotepa—sarcoma	0.000352	0.00294	CcSEcCtD
Vorinostat—Shock—Mitoxantrone—sarcoma	0.000349	0.00292	CcSEcCtD
Vorinostat—Muscle spasms—Etoposide—sarcoma	0.000348	0.0029	CcSEcCtD
Vorinostat—Thrombocytopenia—Mitoxantrone—sarcoma	0.000348	0.0029	CcSEcCtD
Vorinostat—Anorexia—Vincristine—sarcoma	0.000348	0.0029	CcSEcCtD
Vorinostat—Lethargy—Epirubicin—sarcoma	0.000344	0.00287	CcSEcCtD
Vorinostat—Anorexia—Mitoxantrone—sarcoma	0.000338	0.00283	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Epirubicin—sarcoma	0.000337	0.00281	CcSEcCtD
Vorinostat—Anaemia—Etoposide—sarcoma	0.000334	0.00279	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00033	0.00276	CcSEcCtD
Vorinostat—Body temperature increased—Thiotepa—sarcoma	0.000325	0.00271	CcSEcCtD
Vorinostat—Leukopenia—Etoposide—sarcoma	0.000324	0.0027	CcSEcCtD
Vorinostat—Body temperature increased—Dactinomycin—sarcoma	0.000323	0.00269	CcSEcCtD
Vorinostat—Loss of consciousness—Etoposide—sarcoma	0.000318	0.00266	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—sarcoma	0.000318	0.00266	CcSEcCtD
Vorinostat—Decreased appetite—Vincristine—sarcoma	0.000317	0.00265	CcSEcCtD
Vorinostat—Cough—Etoposide—sarcoma	0.000316	0.00264	CcSEcCtD
Vorinostat—Blood creatinine increased—Epirubicin—sarcoma	0.000316	0.00263	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Vincristine—sarcoma	0.000315	0.00263	CcSEcCtD
Vorinostat—Fatigue—Vincristine—sarcoma	0.000314	0.00262	CcSEcCtD
Vorinostat—Dehydration—Epirubicin—sarcoma	0.000313	0.00262	CcSEcCtD
Vorinostat—Constipation—Vincristine—sarcoma	0.000312	0.0026	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000312	0.0026	CcSEcCtD
Vorinostat—Decreased appetite—Mitoxantrone—sarcoma	0.000309	0.00258	CcSEcCtD
Vorinostat—Chest pain—Etoposide—sarcoma	0.000308	0.00257	CcSEcCtD
Vorinostat—Hypokalaemia—Epirubicin—sarcoma	0.000307	0.00256	CcSEcCtD
Vorinostat—Fatigue—Mitoxantrone—sarcoma	0.000306	0.00256	CcSEcCtD
Vorinostat—Constipation—Mitoxantrone—sarcoma	0.000304	0.00253	CcSEcCtD
Vorinostat—Asthenia—Thiotepa—sarcoma	0.000295	0.00246	CcSEcCtD
Vorinostat—Infection—Etoposide—sarcoma	0.000293	0.00245	CcSEcCtD
Vorinostat—Asthenia—Dactinomycin—sarcoma	0.000293	0.00244	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—sarcoma	0.000292	0.00244	CcSEcCtD
Vorinostat—Pruritus—Thiotepa—sarcoma	0.000291	0.00243	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—sarcoma	0.00029	0.00242	CcSEcCtD
Vorinostat—Thrombocytopenia—Etoposide—sarcoma	0.000289	0.00241	CcSEcCtD
Vorinostat—Body temperature increased—Vincristine—sarcoma	0.000288	0.00241	CcSEcCtD
Vorinostat—Hypokalaemia—Doxorubicin—sarcoma	0.000284	0.00237	CcSEcCtD
Vorinostat—Anorexia—Etoposide—sarcoma	0.000282	0.00235	CcSEcCtD
Vorinostat—Diarrhoea—Thiotepa—sarcoma	0.000281	0.00235	CcSEcCtD
Vorinostat—Body temperature increased—Mitoxantrone—sarcoma	0.000281	0.00234	CcSEcCtD
Vorinostat—Diarrhoea—Dactinomycin—sarcoma	0.000279	0.00233	CcSEcCtD
Vorinostat—Pancytopenia—Epirubicin—sarcoma	0.000276	0.00231	CcSEcCtD
Vorinostat—Neutropenia—Epirubicin—sarcoma	0.000272	0.00227	CcSEcCtD
Vorinostat—Dizziness—Thiotepa—sarcoma	0.000272	0.00227	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Epirubicin—sarcoma	0.000271	0.00226	CcSEcCtD
Vorinostat—Weight decreased—Epirubicin—sarcoma	0.000263	0.0022	CcSEcCtD
Vorinostat—Hyperglycaemia—Epirubicin—sarcoma	0.000263	0.00219	CcSEcCtD
Vorinostat—Asthenia—Vincristine—sarcoma	0.000262	0.00218	CcSEcCtD
Vorinostat—Vomiting—Thiotepa—sarcoma	0.000261	0.00218	CcSEcCtD
Vorinostat—Vomiting—Dactinomycin—sarcoma	0.000259	0.00217	CcSEcCtD
Vorinostat—Headache—Thiotepa—sarcoma	0.000258	0.00215	CcSEcCtD
Vorinostat—Decreased appetite—Etoposide—sarcoma	0.000257	0.00214	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—sarcoma	0.000256	0.00214	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Etoposide—sarcoma	0.000255	0.00213	CcSEcCtD
Vorinostat—Asthenia—Mitoxantrone—sarcoma	0.000255	0.00213	CcSEcCtD
Vorinostat—Fatigue—Etoposide—sarcoma	0.000255	0.00213	CcSEcCtD
Vorinostat—Constipation—Etoposide—sarcoma	0.000253	0.00211	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—sarcoma	0.000252	0.0021	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00025	0.00209	CcSEcCtD
Vorinostat—Diarrhoea—Vincristine—sarcoma	0.000249	0.00208	CcSEcCtD
Vorinostat—Nausea—Thiotepa—sarcoma	0.000244	0.00204	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—sarcoma	0.000244	0.00203	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—sarcoma	0.000243	0.00203	CcSEcCtD
Vorinostat—Diarrhoea—Mitoxantrone—sarcoma	0.000243	0.00203	CcSEcCtD
Vorinostat—Nausea—Dactinomycin—sarcoma	0.000242	0.00202	CcSEcCtD
Vorinostat—Dizziness—Vincristine—sarcoma	0.000241	0.00201	CcSEcCtD
Vorinostat—Body temperature increased—Etoposide—sarcoma	0.000233	0.00195	CcSEcCtD
Vorinostat—Vomiting—Vincristine—sarcoma	0.000232	0.00194	CcSEcCtD
Vorinostat—Oedema peripheral—Epirubicin—sarcoma	0.00023	0.00192	CcSEcCtD
Vorinostat—Headache—Vincristine—sarcoma	0.000228	0.00191	CcSEcCtD
Vorinostat—Vomiting—Mitoxantrone—sarcoma	0.000226	0.00188	CcSEcCtD
Vorinostat—Headache—Mitoxantrone—sarcoma	0.000222	0.00186	CcSEcCtD
Vorinostat—Nausea—Vincristine—sarcoma	0.000217	0.00181	CcSEcCtD
Vorinostat—Oedema peripheral—Doxorubicin—sarcoma	0.000212	0.00177	CcSEcCtD
Vorinostat—Asthenia—Etoposide—sarcoma	0.000212	0.00177	CcSEcCtD
Vorinostat—Nausea—Mitoxantrone—sarcoma	0.000211	0.00176	CcSEcCtD
Vorinostat—Chills—Epirubicin—sarcoma	0.000209	0.00175	CcSEcCtD
Vorinostat—Pruritus—Etoposide—sarcoma	0.000209	0.00174	CcSEcCtD
Vorinostat—Alopecia—Epirubicin—sarcoma	0.000206	0.00172	CcSEcCtD
Vorinostat—Diarrhoea—Etoposide—sarcoma	0.000202	0.00169	CcSEcCtD
Vorinostat—Dysgeusia—Epirubicin—sarcoma	0.000199	0.00166	CcSEcCtD
Vorinostat—Dizziness—Etoposide—sarcoma	0.000195	0.00163	CcSEcCtD
Vorinostat—Muscle spasms—Epirubicin—sarcoma	0.000195	0.00163	CcSEcCtD
Vorinostat—Chills—Doxorubicin—sarcoma	0.000193	0.00162	CcSEcCtD
Vorinostat—Alopecia—Doxorubicin—sarcoma	0.000191	0.00159	CcSEcCtD
Vorinostat—Vomiting—Etoposide—sarcoma	0.000188	0.00157	CcSEcCtD
Vorinostat—Anaemia—Epirubicin—sarcoma	0.000187	0.00157	CcSEcCtD
Vorinostat—Headache—Etoposide—sarcoma	0.000185	0.00154	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—sarcoma	0.000184	0.00153	CcSEcCtD
Vorinostat—Syncope—Epirubicin—sarcoma	0.000182	0.00152	CcSEcCtD
Vorinostat—Leukopenia—Epirubicin—sarcoma	0.000182	0.00152	CcSEcCtD
Vorinostat—Muscle spasms—Doxorubicin—sarcoma	0.00018	0.00151	CcSEcCtD
Vorinostat—Loss of consciousness—Epirubicin—sarcoma	0.000178	0.00149	CcSEcCtD
Vorinostat—Cough—Epirubicin—sarcoma	0.000177	0.00148	CcSEcCtD
Vorinostat—Nausea—Etoposide—sarcoma	0.000175	0.00146	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—sarcoma	0.000173	0.00145	CcSEcCtD
Vorinostat—Chest pain—Epirubicin—sarcoma	0.000173	0.00144	CcSEcCtD
Vorinostat—Dry mouth—Epirubicin—sarcoma	0.000169	0.00141	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—sarcoma	0.000168	0.00141	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—sarcoma	0.000168	0.0014	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—sarcoma	0.000165	0.00138	CcSEcCtD
Vorinostat—Infection—Epirubicin—sarcoma	0.000164	0.00137	CcSEcCtD
Vorinostat—Cough—Doxorubicin—sarcoma	0.000164	0.00137	CcSEcCtD
Vorinostat—Shock—Epirubicin—sarcoma	0.000163	0.00136	CcSEcCtD
Vorinostat—Thrombocytopenia—Epirubicin—sarcoma	0.000162	0.00135	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—sarcoma	0.00016	0.00133	CcSEcCtD
Vorinostat—Anorexia—Epirubicin—sarcoma	0.000158	0.00132	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—sarcoma	0.000156	0.0013	CcSEcCtD
Vorinostat—Infection—Doxorubicin—sarcoma	0.000152	0.00127	CcSEcCtD
Vorinostat—Shock—Doxorubicin—sarcoma	0.000151	0.00126	CcSEcCtD
Vorinostat—Thrombocytopenia—Doxorubicin—sarcoma	0.00015	0.00125	CcSEcCtD
Vorinostat—Anorexia—Doxorubicin—sarcoma	0.000146	0.00122	CcSEcCtD
Vorinostat—Decreased appetite—Epirubicin—sarcoma	0.000144	0.0012	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Epirubicin—sarcoma	0.000143	0.00119	CcSEcCtD
Vorinostat—Fatigue—Epirubicin—sarcoma	0.000143	0.00119	CcSEcCtD
Vorinostat—Constipation—Epirubicin—sarcoma	0.000142	0.00118	CcSEcCtD
Vorinostat—Decreased appetite—Doxorubicin—sarcoma	0.000133	0.00111	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000132	0.0011	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—sarcoma	0.000132	0.0011	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—sarcoma	0.000131	0.00109	CcSEcCtD
Vorinostat—Body temperature increased—Epirubicin—sarcoma	0.000131	0.00109	CcSEcCtD
Vorinostat—Body temperature increased—Doxorubicin—sarcoma	0.000121	0.00101	CcSEcCtD
Vorinostat—Asthenia—Epirubicin—sarcoma	0.000119	0.000992	CcSEcCtD
Vorinostat—Pruritus—Epirubicin—sarcoma	0.000117	0.000978	CcSEcCtD
Vorinostat—Diarrhoea—Epirubicin—sarcoma	0.000113	0.000946	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—sarcoma	0.00011	0.000918	CcSEcCtD
Vorinostat—Dizziness—Epirubicin—sarcoma	0.000109	0.000914	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—sarcoma	0.000108	0.000905	CcSEcCtD
Vorinostat—Vomiting—Epirubicin—sarcoma	0.000105	0.000879	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—sarcoma	0.000105	0.000875	CcSEcCtD
Vorinostat—Headache—Epirubicin—sarcoma	0.000104	0.000866	CcSEcCtD
Vorinostat—Dizziness—Doxorubicin—sarcoma	0.000101	0.000846	CcSEcCtD
Vorinostat—Nausea—Epirubicin—sarcoma	9.83e-05	0.000821	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—sarcoma	9.74e-05	0.000813	CcSEcCtD
Vorinostat—Headache—Doxorubicin—sarcoma	9.6e-05	0.000801	CcSEcCtD
Vorinostat—Nausea—Doxorubicin—sarcoma	9.1e-05	0.00076	CcSEcCtD
Vorinostat—HDAC11—Disease—EGFR—sarcoma	3.6e-05	0.000147	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—NRAS—sarcoma	3.59e-05	0.000147	CbGpPWpGaD
Vorinostat—HDAC3—Developmental Biology—HRAS—sarcoma	3.57e-05	0.000146	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KDR—sarcoma	3.55e-05	0.000145	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KIT—sarcoma	3.55e-05	0.000145	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PDGFRA—sarcoma	3.55e-05	0.000145	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle, Mitotic—MYC—sarcoma	3.53e-05	0.000144	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PLCG1—sarcoma	3.5e-05	0.000143	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IGF1R—sarcoma	3.48e-05	0.000142	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MDM2—sarcoma	3.44e-05	0.000141	CbGpPWpGaD
Vorinostat—HDAC4—Disease—CTNNB1—sarcoma	3.44e-05	0.00014	CbGpPWpGaD
Vorinostat—HDAC6—Disease—SRC—sarcoma	3.44e-05	0.00014	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CREB1—sarcoma	3.43e-05	0.00014	CbGpPWpGaD
Vorinostat—HDAC11—Disease—KRAS—sarcoma	3.4e-05	0.000139	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CREB1—sarcoma	3.37e-05	0.000138	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CXCR4—sarcoma	3.37e-05	0.000138	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—EGFR—sarcoma	3.33e-05	0.000136	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KDR—sarcoma	3.32e-05	0.000136	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—FOXO1—sarcoma	3.32e-05	0.000135	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PDGFRB—sarcoma	3.31e-05	0.000135	CbGpPWpGaD
Vorinostat—HDAC6—Disease—NRAS—sarcoma	3.31e-05	0.000135	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL2—sarcoma	3.29e-05	0.000134	CbGpPWpGaD
Vorinostat—NCOR1—Developmental Biology—HRAS—sarcoma	3.28e-05	0.000134	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KIT—sarcoma	3.27e-05	0.000134	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PDGFRA—sarcoma	3.26e-05	0.000133	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CCND1—sarcoma	3.21e-05	0.000131	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—JUN—sarcoma	3.2e-05	0.000131	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—CTNNB1—sarcoma	3.18e-05	0.00013	CbGpPWpGaD
Vorinostat—HDAC8—Disease—CTNNB1—sarcoma	3.17e-05	0.00013	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—MYC—sarcoma	3.15e-05	0.000129	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—KRAS—sarcoma	3.14e-05	0.000128	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFC—sarcoma	3.12e-05	0.000128	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CREB1—sarcoma	3.11e-05	0.000127	CbGpPWpGaD
Vorinostat—HDAC4—Disease—SRC—sarcoma	3.11e-05	0.000127	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MDM2—sarcoma	3.09e-05	0.000126	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—KRAS—sarcoma	3.09e-05	0.000126	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MDM2—sarcoma	3.09e-05	0.000126	CbGpPWpGaD
Vorinostat—HDAC6—Disease—MYC—sarcoma	3.08e-05	0.000126	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KIT—sarcoma	3.06e-05	0.000125	CbGpPWpGaD
Vorinostat—HDAC6—Disease—EGFR—sarcoma	3.01e-05	0.000123	CbGpPWpGaD
Vorinostat—HDAC4—Disease—NRAS—sarcoma	2.99e-05	0.000122	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KDR—sarcoma	2.98e-05	0.000122	CbGpPWpGaD
Vorinostat—HDAC9—Disease—CTNNB1—sarcoma	2.97e-05	0.000121	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KIT—sarcoma	2.94e-05	0.00012	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CREB1—sarcoma	2.91e-05	0.000119	CbGpPWpGaD
Vorinostat—HDAC11—Disease—HRAS—sarcoma	2.89e-05	0.000118	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—SRC—sarcoma	2.87e-05	0.000117	CbGpPWpGaD
Vorinostat—HDAC8—Disease—SRC—sarcoma	2.87e-05	0.000117	CbGpPWpGaD
Vorinostat—HDAC6—Disease—KRAS—sarcoma	2.85e-05	0.000116	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MDM2—sarcoma	2.84e-05	0.000116	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IGF1R—sarcoma	2.84e-05	0.000116	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CREB1—sarcoma	2.8e-05	0.000114	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—VEGFA—sarcoma	2.8e-05	0.000114	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MDM2—sarcoma	2.79e-05	0.000114	CbGpPWpGaD
Vorinostat—HDAC4—Disease—MYC—sarcoma	2.79e-05	0.000114	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—NRAS—sarcoma	2.76e-05	0.000113	CbGpPWpGaD
Vorinostat—HDAC8—Disease—NRAS—sarcoma	2.76e-05	0.000113	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL2—sarcoma	2.76e-05	0.000113	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—IL2—sarcoma	2.75e-05	0.000112	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KIT—sarcoma	2.75e-05	0.000112	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—TP53—sarcoma	2.74e-05	0.000112	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KDR—sarcoma	2.74e-05	0.000112	CbGpPWpGaD
Vorinostat—HDAC4—Disease—EGFR—sarcoma	2.72e-05	0.000111	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—FOXO1—sarcoma	2.7e-05	0.00011	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PDGFRB—sarcoma	2.7e-05	0.00011	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CCND1—sarcoma	2.69e-05	0.00011	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—JUN—sarcoma	2.68e-05	0.00011	CbGpPWpGaD
Vorinostat—HDAC9—Disease—SRC—sarcoma	2.68e-05	0.00011	CbGpPWpGaD
Vorinostat—HDAC2—Signaling by NGF—HRAS—sarcoma	2.67e-05	0.000109	CbGpPWpGaD
Vorinostat—HDAC3—Disease—CTNNB1—sarcoma	2.67e-05	0.000109	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—CTNNB1—sarcoma	2.66e-05	0.000109	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PDGFRA—sarcoma	2.66e-05	0.000108	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—HRAS—sarcoma	2.63e-05	0.000107	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CREB1—sarcoma	2.62e-05	0.000107	CbGpPWpGaD
Vorinostat—HDAC1—Cell Cycle—TP53—sarcoma	2.59e-05	0.000106	CbGpPWpGaD
Vorinostat—HDAC9—Disease—NRAS—sarcoma	2.58e-05	0.000105	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MDM2—sarcoma	2.58e-05	0.000105	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—MYC—sarcoma	2.57e-05	0.000105	CbGpPWpGaD
Vorinostat—HDAC4—Disease—KRAS—sarcoma	2.57e-05	0.000105	CbGpPWpGaD
Vorinostat—HDAC8—Disease—MYC—sarcoma	2.57e-05	0.000105	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KIT—sarcoma	2.53e-05	0.000103	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—EGFR—sarcoma	2.52e-05	0.000103	CbGpPWpGaD
Vorinostat—HDAC8—Disease—EGFR—sarcoma	2.51e-05	0.000103	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—MYC—sarcoma	2.51e-05	0.000103	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FLT1—sarcoma	2.5e-05	0.000102	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL2—sarcoma	2.49e-05	0.000102	CbGpPWpGaD
Vorinostat—HDAC2—Disease—FOXO1—sarcoma	2.49e-05	0.000102	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PDGFRB—sarcoma	2.48e-05	0.000101	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PLCG1—sarcoma	2.45e-05	0.0001	CbGpPWpGaD
Vorinostat—NCOR1—Disease—CTNNB1—sarcoma	2.45e-05	0.0001	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PDGFRA—sarcoma	2.44e-05	9.98e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CCND1—sarcoma	2.43e-05	9.93e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—JUN—sarcoma	2.43e-05	9.91e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—HRAS—sarcoma	2.42e-05	9.88e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—SRC—sarcoma	2.41e-05	9.84e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MDM2—sarcoma	2.41e-05	9.84e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—CTNNB1—sarcoma	2.41e-05	9.83e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—SRC—sarcoma	2.41e-05	9.83e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—MYC—sarcoma	2.4e-05	9.82e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CREB1—sarcoma	2.4e-05	9.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—SRC—sarcoma	2.4e-05	9.81e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—KRAS—sarcoma	2.38e-05	9.71e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—KRAS—sarcoma	2.38e-05	9.7e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCR4—sarcoma	2.36e-05	9.63e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—EGFR—sarcoma	2.35e-05	9.6e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—VEGFA—sarcoma	2.34e-05	9.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—sarcoma	2.34e-05	9.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ATF1—sarcoma	2.33e-05	9.52e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NRAS—sarcoma	2.32e-05	9.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MDM2—sarcoma	2.32e-05	9.46e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NRAS—sarcoma	2.32e-05	9.46e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NRAS—sarcoma	2.31e-05	9.44e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL2—sarcoma	2.3e-05	9.4e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCND1—sarcoma	2.24e-05	9.17e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—JUN—sarcoma	2.24e-05	9.15e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KDR—sarcoma	2.24e-05	9.13e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CTNNB1—sarcoma	2.22e-05	9.08e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KRAS—sarcoma	2.22e-05	9.07e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—SRC—sarcoma	2.22e-05	9.05e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HRAS—sarcoma	2.19e-05	8.93e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—SRC—sarcoma	2.18e-05	8.89e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MDM2—sarcoma	2.16e-05	8.84e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MYC—sarcoma	2.16e-05	8.82e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MYC—sarcoma	2.16e-05	8.81e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL2—sarcoma	2.15e-05	8.79e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MYC—sarcoma	2.14e-05	8.73e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NRAS—sarcoma	2.13e-05	8.7e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—sarcoma	2.12e-05	8.66e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—sarcoma	2.11e-05	8.63e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EGFR—sarcoma	2.11e-05	8.63e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EGFR—sarcoma	2.11e-05	8.62e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCND1—sarcoma	2.1e-05	8.57e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—JUN—sarcoma	2.09e-05	8.55e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NRAS—sarcoma	2.09e-05	8.55e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CTNNB1—sarcoma	2.08e-05	8.49e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KIT—sarcoma	2.06e-05	8.41e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—HRAS—sarcoma	2.02e-05	8.26e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HRAS—sarcoma	2.02e-05	8.25e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SRC—sarcoma	2.01e-05	8.2e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CTNNB1—sarcoma	2e-05	8.16e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—sarcoma	2e-05	8.15e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—sarcoma	1.99e-05	8.14e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—sarcoma	1.99e-05	8.13e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MDM2—sarcoma	1.99e-05	8.12e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—sarcoma	1.98e-05	8.11e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CREB1—sarcoma	1.96e-05	8e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—sarcoma	1.96e-05	7.99e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—sarcoma	1.95e-05	7.97e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—sarcoma	1.94e-05	7.93e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL2—sarcoma	1.93e-05	7.9e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NRAS—sarcoma	1.93e-05	7.89e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—sarcoma	1.91e-05	7.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KIT—sarcoma	1.89e-05	7.74e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HRAS—sarcoma	1.89e-05	7.71e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—sarcoma	1.89e-05	7.7e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—JUN—sarcoma	1.88e-05	7.68e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SRC—sarcoma	1.88e-05	7.67e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—sarcoma	1.87e-05	7.63e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—sarcoma	1.83e-05	7.49e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—sarcoma	1.83e-05	7.47e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IGF1R—sarcoma	1.83e-05	7.47e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NRAS—sarcoma	1.81e-05	7.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SRC—sarcoma	1.81e-05	7.37e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CREB1—sarcoma	1.8e-05	7.37e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—sarcoma	1.8e-05	7.36e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—sarcoma	1.8e-05	7.35e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL2—sarcoma	1.78e-05	7.26e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—sarcoma	1.77e-05	7.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—sarcoma	1.77e-05	7.22e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—sarcoma	1.76e-05	7.19e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—sarcoma	1.74e-05	7.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FOXO1—sarcoma	1.74e-05	7.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PDGFRB—sarcoma	1.74e-05	7.1e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NRAS—sarcoma	1.74e-05	7.09e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—sarcoma	1.73e-05	7.08e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—JUN—sarcoma	1.73e-05	7.06e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—sarcoma	1.72e-05	7.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PDGFRA—sarcoma	1.71e-05	6.99e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HRAS—sarcoma	1.7e-05	6.93e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—HRAS—sarcoma	1.69e-05	6.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—HRAS—sarcoma	1.69e-05	6.91e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SRC—sarcoma	1.69e-05	6.89e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—sarcoma	1.68e-05	6.88e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—sarcoma	1.66e-05	6.79e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—sarcoma	1.65e-05	6.73e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—sarcoma	1.64e-05	6.71e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NRAS—sarcoma	1.62e-05	6.63e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MDM2—sarcoma	1.62e-05	6.62e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—sarcoma	1.62e-05	6.61e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—sarcoma	1.6e-05	6.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—sarcoma	1.58e-05	6.46e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HRAS—sarcoma	1.56e-05	6.37e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—sarcoma	1.56e-05	6.35e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SRC—sarcoma	1.55e-05	6.33e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HRAS—sarcoma	1.53e-05	6.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—sarcoma	1.51e-05	6.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—sarcoma	1.51e-05	6.17e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—sarcoma	1.5e-05	6.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MDM2—sarcoma	1.49e-05	6.09e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NRAS—sarcoma	1.49e-05	6.09e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—sarcoma	1.48e-05	6.04e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—sarcoma	1.48e-05	6.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL2—sarcoma	1.45e-05	5.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KDR—sarcoma	1.44e-05	5.88e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HRAS—sarcoma	1.41e-05	5.77e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—sarcoma	1.41e-05	5.77e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—JUN—sarcoma	1.41e-05	5.76e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—sarcoma	1.4e-05	5.71e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—sarcoma	1.4e-05	5.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—sarcoma	1.39e-05	5.68e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—sarcoma	1.38e-05	5.65e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—sarcoma	1.36e-05	5.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KIT—sarcoma	1.33e-05	5.42e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HRAS—sarcoma	1.32e-05	5.4e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—sarcoma	1.29e-05	5.26e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—sarcoma	1.28e-05	5.24e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HRAS—sarcoma	1.27e-05	5.19e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SRC—sarcoma	1.26e-05	5.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CREB1—sarcoma	1.26e-05	5.16e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—sarcoma	1.24e-05	5.07e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—sarcoma	1.23e-05	5.03e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NRAS—sarcoma	1.22e-05	4.97e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HRAS—sarcoma	1.19e-05	4.85e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SRC—sarcoma	1.16e-05	4.75e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—sarcoma	1.14e-05	4.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—sarcoma	1.13e-05	4.63e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—sarcoma	1.12e-05	4.59e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NRAS—sarcoma	1.12e-05	4.57e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—sarcoma	1.11e-05	4.53e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HRAS—sarcoma	1.09e-05	4.46e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—sarcoma	1.05e-05	4.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MDM2—sarcoma	1.05e-05	4.27e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—sarcoma	1.04e-05	4.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—sarcoma	1.02e-05	4.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—sarcoma	9.63e-06	3.93e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL2—sarcoma	9.34e-06	3.81e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—sarcoma	9.31e-06	3.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—sarcoma	9.1e-06	3.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—JUN—sarcoma	9.08e-06	3.71e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—sarcoma	9.01e-06	3.68e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HRAS—sarcoma	8.9e-06	3.63e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HRAS—sarcoma	8.19e-06	3.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SRC—sarcoma	8.15e-06	3.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—sarcoma	7.94e-06	3.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NRAS—sarcoma	7.84e-06	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—sarcoma	7.3e-06	2.98e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—sarcoma	7.14e-06	2.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—sarcoma	6.75e-06	2.76e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—sarcoma	6e-06	2.45e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HRAS—sarcoma	5.73e-06	2.34e-05	CbGpPWpGaD
